AR Insurance Bulletin 16-2024
Appeals Under "Gold Card" Law
Hugh McDonald
SECRETARY OF COMMERCE
AID
BULLETIN NO. 16-2024
Alan McClain
COMMISSIONER,
ARKANSAS INSURANCE
DEPARTMENT
TO:
ALL LICENSED HEALTH INSURERS, HEALTH MAINTENANCE
ORGANIZATIONS,
HOSPITAL
AND
MEDICAL
SERVICE
CORPORATIONS, ARKANSAS STATE MEDICAL BOARD, ARKANSAS
STATE BOARD OF PHARMACY, AND OTHER INTERESTED PARTIES
FROM:
ARKANSAS INSURANCE DEPARTMENT
DATE:
SEPTEMBER 19, 2024
RE:
APPEALS UNDER "GOLD CARD" LAWS
The purpose of this bulletin is to establish a procedure for the handling of independent
reviews of provider healthcare services prior authorization exemption rescissions,
pursuant to Ark. Code Ann. § 23-99-1123, and prescription drug prior authorization
continuation disallowances, pursuant to Ark. Code Ann. § 23-99-1129.
I.
Appeal of provider healthcare services prior authorization exemption
rescissions.
A.
A healthcare provider has a right to a review of an adverse determination
regarding a prior authorization exemption within twelve (12) months of receiving
proper notice of recission from a healthcare insurer to be conducted by an independent
review organization.
B.
The healthcare provider shall file the appeal in accordance with the healthcare
insurer's instructions, as described in Ark. Code Ann. § 23-99-1122(a)(2)(B)(ii), (iv), and
(v).
C.
When filing the appeal, the healthcare provider may request review of a second
random sample of claims, as authorized under Ark. Code Ann. § 23-99-1123(d)(1), if the
claims information required by Ark. Code Ann. § 23-99-1122(a)(2)(B)(iii) identified that
at least five (5) additional claims were eligible for review but not included in the
original random sample.
D.
Immediately upon receipt of the healthcare provider's appeal request, the
healthcare insurer shall complete a preliminary review of the appeal request to
determine whether:
i.
The healthcare provider has provided all the information required by Ark.
Code Ann. § 23-99-1122(a)(2)(B)(iv)(a)-(c); and
Arkansas Department of Commerce
Arkansas Insurance Department
1 Commerce Way, Suite 102 ' Little Rock, AR 72202
I NSU RAN CE.A R KAN SAS.GOV
ii.
The healthcare provider's appeal is eligible for independent review under
Ark. Code Ann. § 23-99-1123(a)(3), which reads: "[a] healthcare provider who has an
exemption rescinded due to a failure to provide medical records within sixty (60) days
of a record request for a retrospective review shall not be eligible for review of that
rescission by an independent review entity."
E.
The healthcare insurer shall immediately notify the commissioner in writing at
aid.goldcardexemption@arkansas.gov and the healthcare provider in writing regarding
whether the appeal request:
i.
Is complete; and
ii.
Is eligible for independent review under Ark. Code Ann. § 23-99-
1123(a)(3).
F.
If the appeal request is not complete:
i.
The healthcare insurer shall inform the healthcare provider and the
commissioner in writing of the deficiency no later than two (2) business days from the
receipt of the appeal request and shall describe in the notice the information or
materials needed to make complete the request; and
ii.
The provider shall have no more than one (1) business day to provide the
requested materials; and
iii.
The healthcare insurer shall then have one (1) business day to review the
additional materials for completeness and repeat the above described steps in I(E) and,
if necessary, I(F).
G.
Within two (2) business days of receipt of the notice that an appeal is eligible for
independent review, the commissioner shall:
i.
Assign an independent review organization from the list of approved
independent review organizations compiled and maintained by the commissioner to
conduct the review, pursuant to Rule 76, § 12 (eff. Jan. 1, 2025, codified at 23 CAR § 117-
111);
ii.
Notify the healthcare insurer of the name and contact information of the
assigned independent review organization; and
iii.
Notify the healthcare provider of the name of the assigned independent
review organization.
H.
Upon receipt of the name and contact information for the assigned independent
review organization, the healthcare insurer shall provide to the assigned independent
review organization:
2
i.
The information described in Ark. Code Ann. § 23-99-1122(a)(2)(B)(iii);
ii.
Copies of any medical records and documents described in Ark. Code
Ann. § 23-99-1122(c)(1); and
iii.
Any other documents and other information the healthcare insurer
considered in making its decision to rescind the healthcare provider's previous prior
authorization exemption.
I.
If the healthcare provider requested that the independent review organization
consider a second random sample of claims, the healthcare insurer shall have two (2)
business days after receiving the name and contact information for the assigned
independent review organization to provide the assigned independent review
organization with a listing of all payable claims for the same health care service
submitted by the healthcare provider during the evaluation period that were eligible to
be evaluated but that were not included in the original random sample. The listing must
be sufficiently detailed to allow the independent review organization to identify each
payable claim to be used in the second random sample.
J.
If a second random sample is requested, the independent review organization
shall immediately identify, from the list of eligible claims provided by the healthcare
insurer, a second random sample of at least five (5) and no more than twenty (20)
claims.
K.
Once the independent review organization has identified the claims that will
comprise the second random sample, the independent review organization shall in
writing request the corresponding medical records from the healthcare insurer. The
independent review organization shall provide the healthcare provider with written
notice of the request.
L.
With a copy to the healthcare provider, the healthcare insurer shall provide the
requested medical records to the independent review organization no later than two (2)
business days from receipt of the independent review organization's request.
M.
The healthcare provider shall have no more than three (3) business days from the
date it receives the healthcare insurer's response to provide the independent review
organization with any additional medical records necessary for the independent review
organization to review the second random sample of claims.
N.
The independent review organization shall determine whether to affirm or
overturn the health care insurer's determination that less than ninety percent (90%) of
the claims met the applicable medical necessity criteria by reviewing each claim that the
healthcare insurer retrospectively reviewed and determined did not meet the applicable
3
medical necessity criteria and, if applicable, each claim included in the second random
sample identified by the independent review organization.
O.
An independent review organization shall complete a review of an adverse
determination regarding a prior authorization exemption no later than:
i.
Thirty (30) days after the date a healthcare provider files the request for a
review, per Ark. Code Ann. § 23-99-1123(c); or
ii.
Sixty (60) days after the date a healthcare provider files the request for a
review, if the healthcare provider requested a second random sample.
P.
Immediately after reaching its decision, the independent review organization
shall notify the healthcare provider, the healthcare insurer, and the commissioner of its
decision.
II.
Appeal of prescription drug prior authorization continuation disallowance.
A.
If the Arkansas State Board of Pharmacy and the Arkansas State Medical Board
disallow a prior authorization of a prescription drug, medicine, biological product,
pharmaceutical, or pharmaceutical service requested under Ark. Code Ann. § 23-99-
1128, a healthcare insurer, pharmacy benefits manager, or other interested party may
file an appeal to the State Insurance Department within ninety (90) days of the
disallowance of the prior authorization.
B.
The appeal filed with the Insurance Commissioner shall be sent to
aid.goldcardexemption@arkansas.gov and shall include:
i.
A copy of the written request, including any supporting documentation,
the healthcare insurer or pharmacy benefits manager sent the Arkansas State Board of
Pharmacy for any prescription drug, medicine, biological product, pharmaceutical, or
pharmaceutical service to be reviewed for a continuation of prior authorization, as
described in Ark. Code Ann. § 23-99-1128(a).
ii.
A copy of the criteria and procedures adopted by the Arkansas State
Board of Pharmacy and the Arkansas State Medical Board, as described in Ark. Code
Ann. § 23-99-1128(b).
iii.
A copy of the Boards' decision, including any supporting documentation
used to make the decision, as described in Ark. Code Ann. § 23-99-1128(c)(1).
C.
The healthcare insurer shall notify the Arkansas State Board of Pharmacy and the
Arkansas State Medical Board in writing of the appeal but need not include all
attachments described above in II(B)(i)-(iii).
D.
No later than the thirtieth day after the date a healthcare insurer, pharmacy
benefits manager, or other interested party files the appeal, the Insurance
Commissioner shall appoint an independent review organization from the list
4
maintained by the Commissioner pursuant to Rule 76, § 12 (effective Jan. 1, 2025,
codified at 23 CAR § 117-111) to review the appeal and shall submit to the appointed
independent review organization the information described above in II(B)(i)-(iii).
E.
The assigned independent review organization shall review the information
submitted under II(B)(i)-(iii) when deciding whether to uphold or reverse the Boards'
decision to disallow the continuation of prior authorization.
F.
Within forty-five (45) days after the date it receives the appeal, the assigned
independent review organization shall provide written notice of its decision to:
i.
the healthcare insurer, pharmacy benefits manager, or other interested
party that filed the appeal;
ii.
the Arkansas State Board of Pharmacy;
iii.
the Arkansas State Medical Board; and
iv.
the Insurance Commissioner.
For questions related to this Bulletin, please direct all inquiries to AID's Legal
Division at (501) 371-2820 or email insurance.legal@arkansas.gov.
Ca/6
t Ci
f
Alan McClain
Arkansas Insurance Commissioner
Date
5